Hans Tesch
3PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Mar 06, 2024
Efficacy and safety of everolimus plus exemestane in patients with hormone receptor-positive, HER-2-negative advanced breast cancer: Results from the open-label, multicentre, non-interventional BRAWO study.Diana Lüftner, Florian Schuetz, Andreas Schneeweiss
|Feb 28, 2024
Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma.Luciano J Costa, Thomas W LeBlanc, Hans Tesch
|Jul 12, 2018
Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial.Hans Tesch, Oliver Stoetzer, Thomas Decker
Pageof 1
Frequent Collaborators
1 joint publications
Peter A Fasching
1 joint publications
Luciano J Costa
1 joint publications
Thomas W LeBlanc
1 joint publications
Pieter Sonneveld
1 joint publications
Ryan P Kyle
1 joint publications
Liliya Sinyavskaya
1 joint publications
Patrick Hlavacek
1 joint publications
Aster Meche
1 joint publications
Jinma Ren
1 joint publications
Alex Schepart
